Volume 90 Issue 42 | p. 19 | Concentrates
Issue Date: October 15, 2012

Roche Pact Pursues Hearing Loss Drugs

Department: Business
Keywords: drug discovery, hearing loss
[+]Enlarge
Roche says sensorineural hearing loss has no approved pharmaceutical therapies.
Credit: iStock
Stock photo of a woman receiving an ear exam.
 
Roche says sensorineural hearing loss has no approved pharmaceutical therapies.
Credit: iStock

Roche has joined with Inception Sciences and the private equity firm Versant Ventures to create a drug discovery incubator, Inception 3, that will seek treatments for sensorineural hearing loss. The collaboration will pursue drugs that target inner ear hair cell protection and regeneration in the cochlea. It will draw on technology from Stanford University.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment